✦ LIBER ✦

Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment

✍ Scribed by Xiaolei Zhou; David Cella; David Cameron; Mayur M. Amonkar; Anthony Segreti; Steven Stein; Mel Walker; Charles E. Geyer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized phase II study of lapatinib p

✍ Nancy U. Lin; Wolfgang Eierman; Richard Greil; Mario Campone; Bella Kaufman; Kla 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 189 KB

Efficacy and safety of trastuzumab plus

✍ Tomo Osako; Yoshinori Ito; Shunji Takahashi; Nahomi Tokudome; Takuji Iwase; Kiyo 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 293 KB

A phase III randomized comparison of lap

✍ David Cameron; Michelle Casey; Michael Press; Deborah Lindquist; Tadeusz Pienkow 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 330 KB

Phase II trial of a novel capecitabine d

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

A phase II study of trastuzumab and cape

✍ Daigo Yamamoto; Satoru Iwase; Kaoru Kitamura; Hiroki Odagiri; Chizuko Yamamoto; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 232 KB

Survival-adjusted health-related quality

✍ David Cella; Molin Wang; Lynne Wagner; Kathy Miller 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 241 KB